There have been a wide variety of studies examining the exposure of medical students (both at the preclinical and clinical level) to either drug reps and/or the wider pharmaceutical industry during their undergraduate degrees . Periodically, researchers bring all the relevant studies about a topic into bigger papers known as systematic reviews. There has been one systematic review looking specifically at how students interact with the pharmaceutical industry .
Nearly all of the papers used in this systematic review, however, have been conducted in the United States or countries within Europe including France and Germany [1-3]. Only one